{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:47:59Z","timestamp":1792511279192,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10067-016-3453-0","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T02:07:57Z","timestamp":1476929277000},"page":"469-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis"],"prefix":"10.1007","volume":"36","author":[{"given":"Angela","family":"Ceribelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Isailovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Generali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Fredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"issue":"1","key":"3453_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/joim.12524","volume":"280","author":"IE Lundberg","year":"2016","unstructured":"Lundberg IE et al (2016) Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med 280(1):39\u201351","journal-title":"J Intern Med"},{"key":"3453_CR2","doi-asserted-by":"crossref","unstructured":"Ceribelli A. et al. (2016) The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review. Clin Rev Allergy Immunol","DOI":"10.1007\/s12016-016-8527-x"},{"key":"3453_CR3","doi-asserted-by":"crossref","unstructured":"Gunawardena H. (2015) The Clinical Features of Myositis-Associated Autoantibodies: a Review. Clin Rev Allergy Immunol","DOI":"10.1007\/s12016-015-8513-8"},{"key":"3453_CR4","doi-asserted-by":"crossref","unstructured":"Satoh M. et al. (2015) A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy. Clin Rev Allergy Immunol","DOI":"10.1007\/s12016-015-8510-y"},{"issue":"2","key":"3453_CR5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0889-857X(21)00737-7","volume":"18","author":"IN Targoff","year":"1992","unstructured":"Targoff IN (1992) Autoantibodies in polymyositis. Rheum Dis Clin N Am 18(2):455\u2013482","journal-title":"Rheum Dis Clin N Am"},{"issue":"6","key":"3453_CR6","first-page":"891","volume":"32","author":"A Ceribelli","year":"2014","unstructured":"Ceribelli A et al (2014) Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis\/dermatomyositis. Clin Exp Rheumatol 32(6):891\u2013897","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"3453_CR7","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar3802","volume":"14","author":"M Satoh","year":"2012","unstructured":"Satoh M et al (2012) Autoantibodies to transcription intermediary factor TIF1beta associated with dermatomyositis. Arthritis Res Ther 14(2):R79","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3453_CR8","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/annrheumdis-2015-207509","volume":"75","author":"DF Fiorentino","year":"2016","unstructured":"Fiorentino DF et al (2016) PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjogren's syndrome. Ann Rheum Dis 75(6):1145\u20131151","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3453_CR9","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3899\/jrheum.100316","volume":"37","author":"A Ceribelli","year":"2010","unstructured":"Ceribelli A et al (2010) Anti-Th\/To are common antinucleolar autoantibodies in Italian patients with scleroderma. J Rheumatol 37(10):2071\u20132075","journal-title":"J Rheumatol"},{"issue":"2","key":"3453_CR10","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","volume":"14","author":"A Ceribelli","year":"2012","unstructured":"Ceribelli A et al (2012) Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis. Arthritis Res Ther 14(2):R97","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3453_CR11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/14397595.2015.1091155","volume":"26","author":"Y Yamasaki","year":"2016","unstructured":"Yamasaki Y et al (2016) Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52. Mod Rheumatol 26(3):403\u2013409","journal-title":"Mod Rheumatol"},{"issue":"8","key":"3453_CR12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/RHU.0000000000000199","volume":"20","author":"P Palaniappan","year":"2014","unstructured":"Palaniappan P, Lionel AP, Kumar S (2014) Successful treatment of calcinosis cutis in juvenile dermatomyositis with pamidronate. J Clin Rheumatol 20(8):454\u2013455","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"3453_CR13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","volume":"92","author":"LG Rider","year":"2013","unstructured":"Rider LG et al (2013) The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92(4):223\u2013243","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"3453_CR14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","volume":"71","author":"Y Ichimura","year":"2012","unstructured":"Ichimura Y et al (2012) Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis 71(5):710\u2013713","journal-title":"Ann Rheum Dis"},{"key":"3453_CR15","doi-asserted-by":"crossref","unstructured":"Tiniakou, E. and A.L. Mammen, Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review. Clin Rev Allergy Immunol, 2015.","DOI":"10.1007\/s12016-015-8511-x"},{"issue":"6","key":"3453_CR16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/BOR.0b013e32833f1075","volume":"22","author":"A Selva-O'Callaghan","year":"2010","unstructured":"Selva-O'Callaghan A et al (2010) Malignancy and myositis: novel autoantibodies and new insights. Curr Opin Rheumatol 22(6):627\u2013632","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"3453_CR17","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","volume":"54","author":"IN Targoff","year":"2006","unstructured":"Targoff IN et al (2006) A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum 54(11):3682\u20133689","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3453_CR18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","volume":"47","author":"H Gunawardena","year":"2008","unstructured":"Gunawardena H et al (2008) Clinical associations of autoantibodies to a p155\/140\u00a0kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford) 47(3):324\u2013328","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3453_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","volume":"46","author":"K Kaji","year":"2007","unstructured":"Kaji K et al (2007) Identification of a novel autoantibody reactive with 155 and 140\u00a0kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford) 46(1):25\u201328","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"3453_CR20","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","volume":"66","author":"H Chinoy","year":"2007","unstructured":"Chinoy H et al (2007) The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 66(10):1345\u20131349","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3453_CR21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/03009740802687455","volume":"38","author":"K Fujikawa","year":"2009","unstructured":"Fujikawa K et al (2009) Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155\/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study. Scand J Rheumatol 38(4):263\u2013267","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"3453_CR22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.autrev.2015.10.007","volume":"15","author":"C Selmi","year":"2016","unstructured":"Selmi C et al (2016) Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15\u00a0years. Autoimmun Rev 15(2):162\u2013166","journal-title":"Autoimmun Rev"},{"key":"3453_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","volume":"433","author":"I Cavazzana","year":"2016","unstructured":"Cavazzana I et al (2016) Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera. J Immunol Methods 433:1\u20135","journal-title":"J Immunol Methods"},{"issue":"8","key":"3453_CR24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/0961203316640920","volume":"25","author":"EK Chan","year":"2016","unstructured":"Chan EK et al (2016) Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015. Lupus 25(8):797\u2013804","journal-title":"Lupus"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3453-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3453-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3453-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T19:55:47Z","timestamp":1657482947000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3453-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3453"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3453-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,20]]}}}